Cargando…
Characterization of monocarboxylate transporters (MCTs) expression in soft tissue sarcomas: distinct prognostic impact of MCT1 sub-cellular localization
BACKGROUND: Soft tissue sarcomas (STSs) are a group of neoplasms, which, despite current therapeutic advances, still confer a poor outcome to half of the patients. As other solid tumors, STSs exhibit high glucose consumption rates, associated with worse prognosis and therapeutic response. As highly...
Autores principales: | Pinheiro, Céline, Penna, Valter, Morais-Santos, Filipa, Abrahão-Machado, Lucas F, Ribeiro, Guilherme, Curcelli, Emílio C, Olivieri, Marcus V, Morini, Sandra, Valença, Isabel, Ribeiro, Daniela, Schmitt, Fernando C, Reis, Rui M, Baltazar, Fátima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036386/ https://www.ncbi.nlm.nih.gov/pubmed/24885736 http://dx.doi.org/10.1186/1479-5876-12-118 |
Ejemplares similares
-
Clinical impact of the metabolic phenotype of prostate cancer: role of monocarboxylate transporters (MCTs)
por: Pértega-Gomes, Nelma, et al.
Publicado: (2013) -
Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer
por: Pértega-Gomes, Nelma, et al.
Publicado: (2011) -
Natural Autoimmunity to the Thyroid Hormone Monocarboxylate Transporters MCT8 and MCT10
por: Porst, Theresa, et al.
Publicado: (2021) -
Importance of lactate dehydrogenase (LDH) and monocarboxylate transporters (MCTs) in cancer cells
por: Hatami, Hamed, et al.
Publicado: (2022) -
Monocarboxylate Transporter 1 (MCT1) in Liver Pathology
por: Droździk, Marek, et al.
Publicado: (2020)